Gastric Cancer Clinical Trials in Avignon
2 recruitingAvignon, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 2
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group120 enrolled37 locationsNCT06253611